Please login to the form below

Not currently logged in
Email:
Password:

Prosensa

This page shows the latest Prosensa news and features for those working in and with pharma, biotech and healthcare.

BioMarin gives up on muscular dystrophy drug

BioMarin gives up on muscular dystrophy drug

The announcement marks the culmination of an expensive gamble for BioMarin, which paid $840m to buy drisapersen's developer Prosensa at the end of 2014.

Latest news

More from news
Approximately 4 fully matching, plus 15 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Shining a light on the true cost of patient care
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS...
city
The real-world data conundrum
How data is changing the healthcare industries...
Where is health behaviour change heading?
Cures rely on patient adherence to succeed, and health behaviour change in any non-compliant patient is essential, this post explores where health behaviour change is heading....

Infographics